Neurocritical care is a specialized medical field that focuses on the management and treatment of patients with critical neurological conditions. These conditions often involve severe injuries or diseases affecting the brain, spinal cord, or peripheral nerves, requiring immediate and intensive medical intervention. The primary goal of neurocritical care is to prevent secondary brain injury and optimize neurological function in patients facing life-threatening neurological conditions. This involves close monitoring of vital signs, neurological status, and intracranial pressure, as well as prompt intervention to prevent complications such as cerebral edema, ischemia, or hemorrhage. Neurocritical care teams typically consist of multidisciplinary specialists, including neurologists, neurosurgeons, critical care physicians, nurses, respiratory therapists, and pharmacists, working collaboratively to provide comprehensive care to patients with complex neurological disorders. Common conditions managed in neurocritical care units include traumatic brain injury, subarachnoid hemorrhage, ischemic and hemorrhagic stroke, status epilepticus, spinal cord injury, and severe neurological infections. Treatment modalities may include neuroprotective strategies, mechanical ventilation, intracranial pressure monitoring, vasopressor therapy, and neurosurgical interventions such as decompressive craniectomy or clot evacuation. Neurocritical care also plays a crucial role in supporting patients through the acute phase of their illness and facilitating their transition to rehabilitation services or long-term care facilities. Additionally, neurocritical care research contributes to advancements in understanding the pathophysiology of neurological diseases and developing innovative treatments to improve patient outcomes.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom